Lexicon Pharmaceuticals Ownership | Who Owns Lexicon Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Lexicon Pharmaceuticals Ownership Summary

Lexicon Pharmaceuticals is owned by 81.54% institutional investors, 1.15% insiders, and 17.31% retail investors. Artal group is the largest institutional shareholder, holding 37.67% of LXRX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 6.81% of its assets in Lexicon Pharmaceuticals shares.

LXRX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Lexicon Pharmaceuticals	81.54%	1.15%	17.31%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Artal group	136.18M	37.67%	$100.77M
Fmr	51.97M	14.38%	$38.38M
Siren	38.92M	10.77%	$28.80M
Blackrock	9.89M	4.03%	$16.62M
Blackrock funding, inc. /de	10.33M	2.86%	$7.63M
Vanguard group	9.88M	2.73%	$7.30M
Point72 asset management	8.99M	2.49%	$6.64M
Schonfeld strategic advisors	7.56M	2.09%	$5.58M
Nantahala capital management	6.60M	1.83%	$4.88M
Geode capital management	3.52M	0.97%	$2.60M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Artal group	136.18M	8.59%	$100.77M
Siren	38.92M	1.27%	$28.80M
Nantahala capital management	6.60M	0.21%	$4.88M
Ikarian capital	1.55M	0.16%	$1.14M
Virtus etf advisers	425.27K	0.13%	$314.06K
Nea management company	2.38M	0.10%	$1.76M
Tang capital management	850.27K	0.04%	$627.92K
Schonfeld strategic advisors	7.56M	0.03%	$5.58M
Rpo	44.24K	0.03%	$32.67K
Cvi	20.00K	0.03%	$33.60K

Top Buyers

Holder	Shares	% Assets	Change
Point72 asset management	8.99M	0.01%	7.76M
Schonfeld strategic advisors	7.56M	0.03%	5.68M
Nantahala capital management	6.60M	0.21%	4.30M
Blackrock	9.89M	0.00%	2.20M
Fmr	51.97M	0.00%	2.10M

Top Sellers

Holder	Shares	% Assets	Change
Orbimed advisors	-	-	-11.02M
Ameriprise financial	-	-	-2.33M
Opaleye management	-	-	-1.88M
Bvf inc/il	-	-	-1.69M
Cubist systematic strategies	-	-	-1.40M

New Positions

Holder	Shares	% Assets	Change	Value
Ikarian capital	1.55M	0.16%	1.55M	$1.14M
Boothbay fund management	480.82K	0.01%	480.82K	$355.09K
Group one trading	314.40K	0.00%	314.40K	$232.19M
Virtu financial	88.98K	0.00%	88.98K	$66.00K
Renaissance	51.14K	0.00%	51.14K	$37.77K

Sold Out

Holder	Change
Federated hermes	-6.00
Capital performance advisors llp	-18.00
Tortoise investment management	-21.00
Nelson, van denburg & campbell wealth management group	-21.00
Rothschild investment	-75.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	122	-12.23%	294,769,499	2.13%	81	1.28%	68	-2.86%	20	-4.76%
Sep 30, 2024	138	6.15%	288,617,050	3.46%	79	0.62%	70	-2.78%	21	-8.70%
Jun 30, 2024	130	6.56%	278,967,822	61.45%	113	1.86%	72	9.09%	23	-20.69%
Mar 31, 2024	122	10.91%	172,789,084	-5.49%	78	1.40%	66	17.86%	29	26.09%
Dec 31, 2023	110	-3.51%	182,824,838	-3.14%	74	0.88%	56	1.82%	23	-20.69%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl S	24.61M	6.81%	34.23K
Fidelity Growth Compy Commingled Pl O	20.40M	5.64%	2.23M
Fidelity Growth Company Fund	16.86M	4.66%	-
Fidelity Growth Company K6	5.40M	1.49%	-137.43K
Vanguard Total Stock Mkt Idx Inv	5.15M	1.42%	-
Fidelity Series Growth Company	4.15M	1.15%	-
Vanguard US Total Market Shares ETF	3.89M	1.08%	-
iShares Russell 2000 ETF	3.05M	0.84%	-26.40K
Vanguard Institutional Extnd Mkt Idx Tr	2.90M	0.80%	-
Columbia Small Cap Value I A	1.91M	0.53%	497.77K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	-

LXRX Ownership FAQ

Who Owns Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals shareholders are primarily institutional investors at 81.54%, followed by 1.15% insiders and 17.31% retail investors. The average institutional ownership in Lexicon Pharmaceuticals's industry, Biotech Stocks , is 68.48%, which Lexicon Pharmaceuticals exceeds.

Who owns the most shares of Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals’s largest shareholders are Artal group (136.18M shares, 37.67%), Fmr (51.97M shares, 14.38%), and Siren (38.92M shares, 10.77%). Together, they hold 62.81% of Lexicon Pharmaceuticals’s total shares outstanding.

Does Blackrock own Lexicon Pharmaceuticals?

Yes, BlackRock owns 4.03% of Lexicon Pharmaceuticals, totaling 9.89M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 16.62M$. In the last quarter, BlackRock increased its holdings by 2.2M shares, a 28.56% change.

Who is Lexicon Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Artal group is Lexicon Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 8.59% of its assets in 136.18M Lexicon Pharmaceuticals shares, valued at 100.77M$.

Who is the top mutual fund holder of Lexicon Pharmaceuticals shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Lexicon Pharmaceuticals shares, with 6.81% of its total shares outstanding invested in 24.61M Lexicon Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools